Hims & Hers Health (HIMS): Hillsdale Investment Management Inc. reduced its stake -87K shares
Hillsdale Investment Management Inc. reduced its stake in Hims & Hers Health, per its Q1 2025 13F.
- 128K
- Shares reported · -87K vs prior quarter
- 0.19%
- Disclosed portfolio weight
- $3.78M
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- May 9, 2025
What stands out in this filing
- 214,500 shares in Q4 2024, 128,000 now (−40.3% in share count).
- Reported at $3.78M, 0.19% of the portfolio value in this 13F filing.
- 9 other tracked managers reported the same kind of change for Q1 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 3, 2025InsiderOfficer sold ~$187K of HIMS shares in the open market
- Mar 11, 2025InsiderOfficer sold ~$77K of HIMS shares in the open market
- Mar 17, 2025Insider · 1 personInsiders: 8 sales (~$6.0M)
- Mar 18, 2025Insider · 4 peopleInsiders: 5 sales (~$3.9M)
- Mar 21, 2025InsiderCFO sold ~$749K of HIMS shares in the open market
- Mar 26, 2025Insider · 1 personInsiders: 5 sales (~$2.4M)
- Mar 31, 2025InsiderOfficer sold ~$90K of HIMS shares in the open market
- Apr 2, 2025InsiderCFO sold ~$339K of HIMS shares in the open market
- Apr 3, 2025InsiderOfficer sold ~$63K of HIMS shares in the open market
- Apr 9, 2025Insider · 1 personInsiders: 4 sales (~$911K)
- Apr 14, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
- Apr 15, 2025InsiderCFO sold ~$330K of HIMS shares in the open market
- Apr 16, 2025Insider · 1 personInsiders: 3 sales (~$2.4M)
- Apr 21, 2025Insider · 1 personInsiders: 2 sales (~$859K)
- Apr 22, 2025InsiderOfficer sold ~$78K of HIMS shares in the open market
- Apr 28, 2025Insider · 2 peopleInsiders: 2 sales (~$1.4M)
- Apr 29, 2025InsiderCEO sold ~$1.82M of HIMS shares in the open market
What came next
- May 12, 2025Insider · 2 peopleInsiders: 5 sales (~$2.0M)
- May 15, 2025InsiderCFO sold ~$697K of HIMS shares in the open market
- May 16, 2025Insider · 1 personInsiders: 7 sales (~$10.3M)
- May 22, 2025InsiderOfficer sold ~$271K of HIMS shares in the open market
- May 27, 2025InsiderOfficer sold ~$181K of HIMS shares in the open market
- May 28, 2025InsiderCFO sold ~$614K of HIMS shares in the open market
- Jun 6, 2025Insider · 1 personInsiders: 2 sales (~$286K)
- Jun 10, 2025InsiderOfficer sold ~$308K of HIMS shares in the open market
- Jun 16, 2025Insider · 2 peopleInsiders: 7 sales (~$10.3M)
- Jun 17, 2025Insider · 4 peopleInsiders: 5 sales (~$5.5M)
- Jun 23, 2025InsiderCFO sold ~$1.09M of HIMS shares in the open market
- Jun 30, 2025InsiderOfficer sold ~$130K of HIMS shares in the open market
- Jul 7, 2025InsiderCFO sold ~$540K of HIMS shares in the open market
- Jul 14, 2025Insider · 2 peopleInsiders: 2 sales (~$675K)
- Jul 16, 2025Insider · 1 personInsiders: 3 sales (~$2.5M)
- Jul 21, 2025Insider · 1 personInsiders: 2 sales (~$1.7M)
- Sep 1, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Hims & Hers Health
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.
How this filing works
Explore the data
Common questions
What does this filing report about Hims & Hers Health (HIMS) stock?
Hillsdale Investment Management Inc. reduced its stake in Hims & Hers Health, per its Q1 2025 13F. Now 128K shares, $3.78M reported value, 0.19% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: May 9, 2025.
What stands out in this filing?
214,500 shares in Q4 2024, 128,000 now (−40.3% in share count). Reported at $3.78M, 0.19% of the portfolio value in this 13F filing. 9 other tracked managers reported the same kind of change for Q1 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Hims & Hers Health recently?
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.
Does this mean HIMS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Hims & Hers Health
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 144Nov 17, 2026
Everything OQRO holds on this company is on its HIMS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
